--- title: "Solesence | 8-K: FY2026 Q1 Revenue: USD 12.96 M" type: "News" locale: "en" url: "https://longbridge.com/en/news/286097612.md" datetime: "2026-05-12T12:17:08.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286097612.md) - [en](https://longbridge.com/en/news/286097612.md) - [zh-HK](https://longbridge.com/zh-HK/news/286097612.md) generator: "portal-rs" --- # Solesence | 8-K: FY2026 Q1 Revenue: USD 12.96 M Revenue: As of FY2026 Q1, the actual value is USD 12.96 M. EPS: As of FY2026 Q1, the actual value is USD -0.01. EBIT: As of FY2026 Q1, the actual value is USD -241 K. Solesence, Inc. reported its financial results for the first quarter ended March 31, 2026, emphasizing operational excellence and new technology commercialization under its Transform and Transcend strategic initiative . #### Revenue - Net revenue for the first quarter of 2026 was $12,957 thousand, decreasing from $14,625 thousand for the same period in 2025 . - Product revenue was $12,919 thousand in Q1 2026, compared to $14,575 thousand in Q1 2025 . - Other revenue was $38 thousand in Q1 2026, down from $50 thousand in Q1 2025 . #### Gross Profit and Margin - Gross profit in Q1 2026 was $3,337 thousand, a slight decrease from $3,382 thousand in Q1 2025 . - Gross margin improved to 26% in Q1 2026, up from 23% in Q1 2025 . - Cost of revenue was $9,620 thousand in Q1 2026, compared to $11,243 thousand in Q1 2025 . #### Operating Expenses - Research and development expense was $1,042 thousand in Q1 2026, compared to $1,018 thousand in Q1 2025 . - Selling, general and administrative expense increased to $2,799 thousand in Q1 2026, from $2,108 thousand in Q1 2025 . #### Profitability - Net loss from operations was -$504 thousand in Q1 2026, a decline from net income from operations of $256 thousand in Q1 2025 . - Net loss for Q1 2026 was -$766 thousand, compared to net income of $80 thousand for Q1 2025 . - Net loss per share-basic was -$0.01 in Q1 2026, compared to $0.00 in Q1 2025 . - Adjusted EBITDA (Non-GAAP) was -$107 thousand in Q1 2026, down from $609 thousand in Q1 2025 . #### Balance Sheet Highlights - Cash decreased to $573 thousand as of March 31, 2026, from $1,288 thousand as of December 31, 2025 . - Trade accounts receivable, net, was $6,379 thousand as of March 31, 2026, compared to $6,836 thousand as of December 31, 2025 . - Inventories, net, stood at $17,559 thousand as of March 31, 2026, down from $18,511 thousand as of December 31, 2025 . - Total current assets were $26,413 thousand as of March 31, 2026, decreasing from $28,776 thousand as of December 31, 2025 . - Total assets were $47,794 thousand as of March 31, 2026, compared to $50,055 thousand as of December 31, 2025 . - Total current liabilities were $12,691 thousand as of March 31, 2026, a decrease from $13,929 thousand as of December 31, 2025 . - Accumulated deficit was -$99,404 thousand as of March 31, 2026, compared to -$98,638 thousand as of December 31, 2025 . #### Outlook / Guidance Solesence, Inc. expects its investments in operational infrastructure, including employee training and organizational restructuring, to position the company for improved operational and financial results through the year . The company is also focused on leveraging its intellectual property, expanding its addressable market, and evolving its service model to drive long-term, sustainable profitability and growth . ### Related Stocks - [SLSN.US](https://longbridge.com/en/quote/SLSN.US.md) ## Related News & Research - [Zenas BioPharma files Form 3 showing InnoCare Pharma stake of 7 million shares](https://longbridge.com/en/news/298305393.md) - [Amazon files Form 3 initial beneficial ownership statement for director Kevin R. Mandia](https://longbridge.com/en/news/298502672.md) - [REG - Sunbelt Rentals Hldg - Publication of Current Report on Form 8-K](https://longbridge.com/en/news/298451503.md) - [Super Hi International files Form 3 initial beneficial ownership statement for CFO Li Lu](https://longbridge.com/en/news/298301990.md) - [First Breach files Form 3 initial beneficial ownership statement for CEO Jeffrey Irwin Low](https://longbridge.com/en/news/298370108.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**